Medincell SA (MEDCL) Stock Price & News

MEDCL:EPA

Medincell SA

€28.44

-0.42%

(-0.12) 1D

Nov 6, 5:35:21 PM GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for MEDCL...

Open

€28.32

High

€28.62

Low

€27.84

Mkt. cap

1.02B

Avg. vol.

141.06K

Volume

71.70K

52-wk high

€36.00

52-wk low

€19.69

EPS

-€0.94

Shares outstanding

35.97M

No. of employees

141

Open

€28.32

High

€28.62

Low

€27.84

Mkt. cap

1.02B

Avg. vol.

141.06K

Volume

71.70K

52-wk high

€36.00

52-wk low

€19.69

EPS

-€0.94

Shares outstanding

35.97M

No. of employees

141

Related stocks

ALVIO

Valerio Therapeutics SA

News stories

From web sources and news partners

BigGo Finance

17 minutes ago

Five S&P Names Put Big Buyback Money to Work as Nasdaq Slips Into Correction

Investing.com

5 minutes ago

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.26%

marketscreener.com

1 hour ago

Nasdaq rebounds but remains on track for fourth straight weekly decline

Yahoo Finance

52 minutes ago

After the Midterm Rally, the Dow Is on Track to Beat the Nasdaq for the First Time Since 2022. Here's What History Says Could Come Next.

About Medincell SA

CEO-

Employees141

Founded2003

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitemedincell.com

All values in EUR	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	7.07M	7.07M	5.06M	5.06M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	6.64M	6.64M	6.63M	6.63M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.74M	3.74M	5.50M	5.50M
Operating expense	10.38M	10.38M	12.13M	12.13M
Total operating expenses	10.38M	10.38M	12.13M	12.13M
Operating income	-3.31M	-3.31M	-7.07M	-7.07M
Other non operating income	-3.31M	-3.31M	612.50K	612.50K
EBT including unusual items	-8.04M	-8.04M	-7.64M	-7.64M
EBT excluding unusual items	-8.04M	-8.04M	-7.62M	-7.62M
Income tax expense	3.00K	3.00K	-37.50K	-37.50K
Effective tax rate	-0.04%	-0.04%	0.49%	0.49%
Other operating expenses	-	-	-	-
Net income	-8.04M	-8.04M	-7.60M	-7.60M
Net profit margin	-113.65%	-113.65%	-150.14%	-150.14%
Earnings per share	-	-	-	-
Interest and investment income	402.00K	402.00K	280.00K	280.00K
Interest expense	-1.37M	-1.37M	-1.39M	-1.39M
Net interest expenses	-965.00K	-965.00K	-1.11M	-1.11M
Depreciation and amortization charges	-	-	-	-
EBITDA	-3.13M	-3.13M	-6.89M	-6.89M
Gain or loss from assets sale	20.00K	20.00K	-	-

Ask anything